跳至主要内容
临床试验/NCT06138249
NCT06138249招募中不适用

Different Kinds of Vitamin D Intake and Its Metabolites: Blood Levels and Bone Mineral Density. A Randomized Clinical Trial.

Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari2 个研究点 分布在 1 个国家目标入组 90 人开始时间: 2023年7月1日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
90
试验地点
2
主要终点
level of Vitamin D

研究概览

简要总结

Patients with hypovitaminosis D are randomized into three arms of treatment:

Group A: Calcifediol 0,266mg each month Group B: Cholecalciferol 25000UI each 15 days Group C: Calcifediol 4 drops per day. Serum levels of vitamin D are dosed after one month of treatment

详细描述

Patients with hypovitaminosis D are randomized into three arms of treatment:

Group A: Calcifediol 0,266mg each month Group B: Cholecalciferol 25000UI each 15 days Group C: Calcifediol 4 drops per day. Serum levels of vitamin D are dosed after one month of treatment to support the best dosage of Vitamin D intake.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Hypovitaminosis D (<20ng/mL)

排除标准

  • Osteoporosis (T score <-2.5SD)
  • Renal or hepatic diseases

结局指标

主要结局

level of Vitamin D

时间窗: Between recruitment and 6 month

Blood dosage of vitamin D

次要结局

  • DEXA(Between recruitment and 18 months)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验